论文部分内容阅读
目的探讨丹红联合前列地尔治疗糖尿病周围神经病变的疗效。方法将106例患者随机分为2组,治疗组予丹红联合前列地尔治疗,对照组单用前列地尔治疗,疗程均为2周,观察治疗前后症状改善情况。结果治疗组临床症状、体征的改善情况均明显优于对照组(P<0.05)。结论丹红联合前列地尔治疗糖尿病周围神经病变安全有效,值得临床推广。
Objective To investigate the efficacy of Danhong combined with alprostadil in the treatment of diabetic peripheral neuropathy. Methods 106 patients were randomly divided into two groups. The treatment group was given Danhong combined with alprostadil. The control group was treated with alprostadil alone for 2 weeks. The improvement of symptoms before and after treatment was observed. Results The improvement of clinical symptoms and signs in the treatment group was significantly better than that in the control group (P <0.05). Conclusion Danhong combined alprostadil treatment of diabetic peripheral neuropathy is safe and effective, worthy of clinical promotion.